Therefore, we conducted CD8+ T-cell-mediated tumor cell killing experiments, as previously described, to evaluate the effects of SPHK1 and MMP1 on the ability of T cells to kill cancer cells in HNSCC. This evidence concerns the gene CD8A and cancer.